Ferguson, Fleur M.; Fedorov, Oleg; Chaikuad, Apirat; Philpott, Martin; Muniz, João Renato Carvalho 
; Felletar, Ildiko; Delft, Frank von; Heightman, Tom; Knapp, Stefan; Abell, Chris; Ciulli, Alessio
Source: Journal of Medicinal Chemistry. Unidade: IFSC
Subjects: INIBIDORES DE ENZIMAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERGUSON, Fleur M. et al. Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain. Journal of Medicinal Chemistry, v. 56, n. 24, p. 10183-10187, 2013Tradução . . Disponível em: https://doi.org/10.1021/jm401582c. Acesso em: 01 nov. 2024.APA
Ferguson, F. M., Fedorov, O., Chaikuad, A., Philpott, M., Muniz, J. R. C., Felletar, I., et al. (2013). Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain. Journal of Medicinal Chemistry, 56( 24), 10183-10187. doi:10.1021/jm401582cNLM
Ferguson FM, Fedorov O, Chaikuad A, Philpott M, Muniz JRC, Felletar I, Delft F von, Heightman T, Knapp S, Abell C, Ciulli A. Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain [Internet]. Journal of Medicinal Chemistry. 2013 ; 56( 24): 10183-10187.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1021/jm401582cVancouver
Ferguson FM, Fedorov O, Chaikuad A, Philpott M, Muniz JRC, Felletar I, Delft F von, Heightman T, Knapp S, Abell C, Ciulli A. Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain [Internet]. Journal of Medicinal Chemistry. 2013 ; 56( 24): 10183-10187.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1021/jm401582c
